Symrise has announced its results for the first half of fiscal 2023. The German ingredients supplier reported sales of €2,414 million, up 6.8 percent on the same period a year ago. EBITDA was down on last year’s figures at €446 million due to a one-time effect relating to the shutdown of the Colonel Island site.
The European Commission has begun a process to end animal testing for chemicals across Europe gradually.
Givaudan has reported solid performance for the first half of 2023.
Chemical giant BASF SE has lowered its annual earnings forecast, attributing this decision to weak global industrial output and lagging consumer product demand.
LVMH has announced a water conservation plan which aims to manage the precious natural resource more efficiently on a global scale, reducing the luxury conglomerate’s consumption by 30 percent by 2030.
At the World Congress of Dermatology in Singapore, L’Oréal has unveiled new research into hormonal variations’ impact on skin and pigmentation conducted by its Vichy and La Roche Posay brands respectively.
Symrise is petitioning the European Union’s General Court to annul the European Commission’s decision to raid fragrance companies in the pursuit of information that would inform any anti-trust case brought against the industry, according to a report published by Reuters.
Evonik has announced the acquisition of Novachem. The Buenos Aires-based sustainable cosmetic actives producer will strengthen the German ingredients supplier’s System Solutions portfolio in the Americas and beyond.
Beiersdorf has established a Joint Innovation Lab with the German Cancer Research Center (DKFZ) aimed at preventing skin cancer and rejuvenating the skin.
Albania is poised to legalise cannabis for medical and industrial use, according to a report published by Balkan Insight.